TY  - GEN
AU  - Zhang,Kai
AU  - Hong,Ruoxi
AU  - Kaping,Lee
AU  - Xu,Fei
AU  - Xia,Wen
AU  - Qin,Ge
AU  - Zheng,Qiufan
AU  - Lu,Qianyi
AU  - Zhai,Qinglian
AU  - Shi,Yanxia
AU  - Yuan,Zhongyu
AU  - Deng,Wuguo
AU  - Chen,Miao
AU  - Wang,Shusen
TI  - CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer
SN  - 1872-7980
PY  - 2019///1213
KW  - Acrylamides
KW  - pharmacology
KW  - Aminoquinolines
KW  - Animals
KW  - Apoptosis
KW  - drug effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Cycle Checkpoints
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cyclin-Dependent Kinase 4
KW  - antagonists & inhibitors
KW  - Cyclin-Dependent Kinase 6
KW  - Female
KW  - G1 Phase
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Piperazines
KW  - Pyridines
KW  - Receptor, ErbB-2
KW  - genetics
KW  - Resting Phase, Cell Cycle
KW  - Xenograft Model Antitumor Assays
KW  - methods
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2019.01.005
ER  -